𝔖 Bobbio Scriptorium
✦   LIBER   ✦

High-dose pergolide monotherapy in the treatment of severe levodopa-induced dyskinesias

✍ Scribed by Alicia Facca; Juan Sanchez-Ramos

Book ID
102506525
Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
348 KB
Volume
11
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis

High-Dose Pergolide Monotherapy in the Treatment of Severe Levodopa-Induced Dyskinesias

To the Editor:

The development of severe, incapacitating, involuntary movements elicited by chronic dopamine replacement therapy in patients with Parkinson's disease (PD) represents one of the most challenging problems confronting

📜 SIMILAR VOLUMES

Open-label pilot study of levetiracetam
Open-label pilot study of levetiracetam (Keppra) for the treatment of levodopa-induced dyskinesias in Parkinson's disease
✍ Theresa A. Zesiewicz; Kelly L. Sullivan; John L. Maldonado; William O. Tatum; Ro 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB 👁 1 views

## Abstract We evaluated the tolerability and preliminary efficacy of levetiracetam (LEV; Keppra) in reducing levodopa‐induced dyskinesias in Parkinson's disease (PD) in an open‐label pilot study. Nine PD patients who were experiencing peak‐dose dyskinesias for at least 25% of the awake day and wer

High-dose cyclophosphamide in the treatm
High-dose cyclophosphamide in the treatment of severe aplastic anemia in children
✍ José Carlos Jaime-Pérez; Oscar González-Llano; David Gómez-Almaguer 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 208 KB 👁 3 views

FL 33612 to permit rapid consideration for publication. ## Mutations in the Factor XI Gene To the Editor: Mutations in the factor XI gene are responsible for a variable bleeding phenotype which correlates poorly with levels of circulating FXI product. We read with interest and concern an article

High-dose escitalopram in the treatment
High-dose escitalopram in the treatment of binge-eating disorder with obesity: a placebo-controlled monotherapy trial
✍ Anna I. Guerdjikova; Susan L. McElroy; Renu Kotwal; Jeffrey A. Welge; Erik Nelso 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB 👁 1 views

## Abstract ## Objective The purpose of this study was to evaluate the efficacy and safety of high‐dose escitalopram in the treatment of binge‐eating disorder (BED) associated with obesity. ## Method Forty‐four outpatients with BED by DSM‐IV criteria and obesity were randomized to receive either